Data on antiretroviral therapy (ART) adherence among prison inmates are limited and not previously synthesized in a systematic manner. The objective of this study was to provide accurate and up-to-date ART adherence estimates among prison inmates. We searched electronic databases for all studies reporting adherence as a primary or secondary outcome among prison inmates. A random-effects model was used to pool adherence rates; sensitivity, heterogeneity and publication bias were assessed. Eleven studies involving 2895 HIV-infected prison inmates were included. The studies were carried out between 1992 and 2011 and reported between 1998 and 2013. A pooled analysis of all studies indicated a pooled estimate of 54.6% (95% confidence interval 48.1-60.9%) of prison inmates had adequate (≥95%) ART adherence. The adherence estimates were significantly higher among cross-studies and studies that used self-reported measures. In summary, our findings indicate that optimal adherence remains a challenge among prison inmates. It is crucial to monitor ART adherence and develop appropriate interventions to improve adherence among these population.
Introduction
It has been documented that there is a higher burden of HIV infection among incarcerated populations in low-, middle-and high-income countries (Jurgens, Nowak, & Day, 2011) as well as its negative impact on continuity of care; development of trust and, subsequently, optimal adherence (Seal, 2005) . Incarceration provides public health opportunity to provide life-saving antiretroviral therapy (ART) to HIV-infected persons; but multiple barriers to ART access, delivery and adherence persist (Chen et al., 2006; Hammett, Kennedy, & Kuck, 2007; Zaller, Thurmond, & Rich, 2007) . Even after release from prisons, non-adherence and loss-to-follow-up have been reported as major issues (Baillargeon et al., 2009) . Of paramount importance while in prison is the necessity to maintain patient confidentiality, in order to avoid perceived and experienced stigma (Ines, Moralejo, Marcos, Fuertes, & Luna, 2008; Pontali, 2005; Rosen et al., 2004; Small, Wood, Betteridge, Montaner, & Kerr, 2009 ) as well as assisting prisoners at delivery to be linked to care in outpatient basis, maintain high level of adherence and re-insertion in the community (Milloy et al., 2011; Springer et al., 2004; Stephenson et al., 2005) . There is limited knowledge on the level of achievable ART adherence in prison globally as well as evidence-based interventions. We therefore conducted a systematic review with metaanalysis to fill this research gap, to provide more accurate and up-to-date ART adherence estimates among prison inmates living with HIV in order to attempt to quantify the burden and inform decision regarding policy responses and public health intervention.
Methods

Protocol and registration
The study background, rationale and methods were specified in advance and documented in a protocol to be published at the international prospective register of systematic reviews (PROSPERO; Number: CRD42016044044) (Uthman, Nduka, & Oladimedji, 2016). outcome. No language, publication date or publication status restrictions were imposed. We excluded studies that involved directly observed ART. Types of participants: HIV-infected prison inmates on ART. Types of outcome measures: adherence rates regardless of measures (such as self-reported and pill count).
Information sources and search strategy
Two of the authors (OAU and OO) conducted searches on the following electronic databases (from 1980 to January 2016): PubMed, EMBASE, SCI Web of Science, NLM Gateway and Google scholar. We used the following keywords: "prisoners", "jail", "adherence", "compliance", "antiretroviral therapy" "HIV"; "HAART"; "ART" (see Appendix 1 for the full Medline search strategy). We searched abstract of relevant conference proceedings from 2006 onward (the most recent ones that may not have been indexed in NLM Gateway meeting abstracts). In addition, the bibliographies of relevant review articles and selected articles were examined for pertinent studies.
Study selection
Two authors (OAU and OO) evaluated the eligibility of studies obtained from the literature search using a predefined protocol, and worked independently to scan all abstracts and obtain full text of articles. In cases of discrepancy, agreement was reached by consensus and by discussions with the third reviewer.
Risk of bias assessment
We used the Risk of Bias Assessment Tool for Nonrandomized Studies (Kim et al., 2013) to appraise the risk of bias for included studies (see Appendix 2). This included information on the selection bias (sample population), selection bias (participation rate), performance bias (outcome assessment), performance bias (analytical methods to control for bias) and other forms of bias. The methodological components of the studies were assessed and classified as adequate, inadequate or unclear. Where differences arose, they were resolved by discussions with the third reviewer.
Data abstraction
Two reviewers (OAU and OO) independently extracted and compared the data. For each study that met the selection criteria, details were extracted on study design, study population characteristics and adherence measures.
Data analysis
For the meta-analysis, we first stabilized the raw ART adherence proportions from each study using the Freeman-Tukey variant of the arcsine square root-transformed proportion (Stuart & Ord, 1994) suitable for pooling. We used a DerSimonian-Laird random-effects model (DerSimonian & Laird, 1986) due to anticipated variations in study population, healthcare delivery systems and epidemic course. To evaluate the stability of the results, we applied several sensitivity analyses, including fixed effects analysis and used a one-study removed approach (Normand, 1999) . The purpose of this analysis was to evaluate the influence of individual studies, by estimating a pooled estimate in the absence of each study. We assessed heterogeneity among trials by inspecting the forest plots and using the chi-squared test for heterogeneity with a 10% level of statistical significance, and using the I 2 statistic where we interpret a value of 50% as representing moderate heterogeneity Higgins, Thompson, Deeks, & Altman, 2003) . We assessed the possibility of publication bias by evaluating a funnel plot for asymmetry. Because graphical evaluation can be subjective, we also conducted an Egger's regression asymmetry test (Egger, Davey, Schneider, & Minder, 1997) as formal statistical tests for publication bias.
The effect of the following study-level factors on the overall adherence rates was explored using subgroup and meta-regression analyses: type of publication (fulltext versus conference abstract), study period (earlier studies conducted before 2000 versus recent studies conducted after 2000), publication year, study design (crosssectional versus cohort), study's region (North America, Europe and sub-Saharan Africa), study size (small:<150 versus large: 150 plus), adherence threshold (≥95% versus 100%) and adherence measures (self-reported versus pharmacy refill). Series of univariable random-effects meta-regression analyses were conducted to investigate the impact of factors on the pooled adherence proportions. Meta-analysis results were reported as combined adherence proportions with 95% confidence intervals (CIs), while meta-regression results are reported as odds ratio with 95% CIs. We assessed the level of agreement between the review authors' reviewers using kappa analysis and reported using the Cohen kappa index (Cohen, 1960) . All p-values were exact and p-value less than .050 was considered statistically significant. Analyses were conducted using Stata version 14 for Windows (Stata Corp, College Station, Texas). This systematic review was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines (http://www. prisma-statement.org) ). The PRISMA checklist is provided in Appendix 3.
Results
Search results and study characteristics Figure 1 shows the study selection flow diagram. The literature search yielded 739 articles of which 29 duplicate records were removed. An additional 672 articles were screened by their titles and abstracts, leaving 38 fulltext articles selected for critical reading (kappa = 0.72; good agreement). Twenty-seven did not meet the inclusion criteria as no relevant outcomes were reported (Appendix 4). Eleven studies yielding a total of 13 adherence estimates met the inclusion criteria and were included (kappa = 1.00; 100% agreement) in the metaanalysis (Catz, Sosman, Scheuerell, & Crumble, 2002; Chen et al., 2013; Chitsaz et al., 2013; Ines et al., 2008; Mostashari, Riley, Selwyn, & Altice, 1998; Palepu et al., 2004; Paparizos et al., 2013; Perez et al., 2006; Soto Blanco, Perez, De Labry Lima, et al., 2005 ; Soto Blanco, Perez, & March, 2005; Wakoli, Baliddawa, Kimaiyo, & Braitstein, 2010) . The sample was composed of 2895 HIV-infected prisoners on ART. Table 1 presents the characteristics of the included studies. The studies were carried out between 1992 and 2011 and reported between 1998 and 2013. Most were reported as journal articles (n = 9, 82%); only two were presented as conference abstracts (18%). When reported the mean age of the participants ranged from 34.0 to 44.7 years and the percentage of drug users ranged from 32% to 100%. The preponderance of the studies (n = 9, 82%) was cross-sectional and two were cohort studies (18%). Most of the studies were conducted in high-income countries (n = 10, 91%) and only one study was conducted in a lowincome country. Studies were carried out in the United States (n = 4, 36%), Spain (n = 4, 36%), Canada (n = 1, 9%), Greece (n = 1, 9%) and Kenya (n = 1, 9%). Most studies measured adherence using self-reported questionnaires (n = 10, 91%); only one study used pharmacy refills. Most of the studies used an adherence threshold of 100% (n = 8, 73%) and three studies a threshold of ≥95% (n = 3, 27%). 
Risk of bias of included studies
The summary risk of bias of included studies is shown in Figure 2 . All studies recruited participants from representative samples; selection bias due to sample population is low in all studies. Selection bias due to participation rate is low in five studies, that is, participation rate was >70-85% in these five studies and unclear in the remaining six studies. Performance bias due to outcome bias was high in all the 11 studies; they all used subjective measures (self-reported questionnaires and pharmacy refill). Performance bias due to confounding was low in five studies that reported adjusted associations, high in two studies and unclear in the remaining four studies. The risk of bias due to other potential bias was low in four studies and unclear in the remaining seven studies.
Overall adherence to ART during and after pregnancy
The proportions of prisoners who achieved adequate adherence levels and 95% CIs from individual studies with a pooled estimate are shown in Figure 3 . The pooled ART adherence proportions for all studies yielded an estimate of 54.6% (95% CI 48.1-60.9%) of patients with adequate ART adherence (≥95%). The I 2 statistics was 90.5%, indicating statistically significant heterogeneity among the studies. The contour-enhanced funnel plot of examination of publication bias is shown in eFigure 1. The funnel plot appears symmetric and shows no evidence of publication bias (p = .631 for Egger's regression asymmetry test). The results of leave-one-study-out sensitivity analyses showed that no study had undue influence on the pooled adherence estimate (eFigure 2).
Adherence to ART by different subgroups
The results of subgroup analyses are shown in Figure 4 . The pooled proportion of prisoners who achieved adequate adherence levels was significantly higher among cross-sectional studies than cohort studies (57.3% versus 38.1%, p-value for interaction = .0001); and was significantly higher among studies that used self-reported measures than the study that used pharmacy refill (56.3% versus 32.7%, p-value for interaction = .0001). However, there was no statistically significant differential proportion of prisoners who achieved adequate adherence levels by other subgroups: type of publication, study period, publication year, region, study size and adherence threshold.
Factors modifying adherence estimates as identified by meta-regression analyses
Factors associated with adherence estimates and proportion of explained variability in adherence estimates as identified by univariable meta-regression analyses are shown in Table 2 . Adherence estimates from crosssectional studies were 94% statistically significantly higher than those from cohort studies (OR = 1.94, 95% CI 1.43-12.62); and adherence estimates from studies that used self-reported measures were 2.4 times higher than those from pharmacy refill measures (OR = 2.44, 95% CI 1.60-3.73). Contrary to expectation, for every 10% increase in the percentage of drug users included in the studies, the adherence estimates increased by 16% (OR = 1.16, 95% CI 1.10-1.29) (eFigure 3). The percentages of drug users, study design and adherence measure explain 40.6%, 24.9% and 20.3% in between study variability in adherence rates, respectively.
Factors associated with adherence rates as reported in individual studies
Seven studies reported factors associated with adherence estimates among prisoners (eFigure 3). The following facilitators of optimal adherence were reported: good patients-physician and peers' relationship, active occupation inside prison, absence of HIV symptoms, good acceptance of treatment and higher educational attainment. While the following barriers of optimal adherence were reported: depressed mood, no social support, "bad" quality food/food insecurity, difficulty in taking medications, previous injecting drug use, active medical problems, alcohol use and younger age.
Discussion
Main findings
To our knowledge, this is the first systematic review and meta-analysis to summarize the available data regarding ART adherence among prison inmates and has brought together evidence from 11 studies incorporating 2895 prison inmates on HIV treatment. We found that the pooled proportion of prison inmates with adequate (≥95%) ART adherence was only about 54.6%, which is still lower compared to other high-risk subgroups, such as HIV-infected drug users (60% [95% CI 52-68%], 38 studies) (Malta, Magnanini, Strathdee, & Bastos, 2010) , HIV-infected female sex workers (76% [95% CI 68-83%], 4 studies) (Mountain et al., 2014) and HIV-infected adolescents (62% [95% CI 57-68%], 50 studies) (Kim, Gerver, Fidler, & Ward, 2014) . Interestingly, ART adherence was twice as high among HIVinfected prisoners in whom adherence was self-reported, compared to those for whom adherence was determined from pharmacy refill records. While self-reports are a validated method for measuring medication adherence (Nguyen, La Caze, & Cottrell, 2014) , we cannot rule out the disproportionately larger number of studies using this tool, as opposed to using pharmacy refill records, which may have biased this result in favour of the former. We also cannot rule out the potential for recall bias when using self-reported measures. Nonetheless, our findings may have important public health implications. For instance, that only one out of two HIV-infected prisoners have optimal ART adherence levels suggests that ART non-adherence constitutes a considerable public health burden, given potential consequences, notably antiretroviral treatment failure and AIDS-specific mortality. Moreover, our meta-analysis was based almost entirely on studies conducted in high-income countries. This potentially suggests that the pooled ART adherence prevalence obtained in our study may be underestimated because prison health services in low-and middle-income countries are less likely to be as comprehensive as prison health services in highincome countries, such that HIV-infected prisoners in the former may be more at risk of ART non-adherence, compared to HIV-infected prisoners in the latter. 
Study limitations and strengths
The results of this meta-analysis should be interpreted with caution. We found statistically significant heterogeneity across the studies, thus suggesting that the percentage of the variability in effect estimates that is due to heterogeneity rather than sampling error (chance) is important. A considerable proportion of the observed heterogeneity may be explained by differences in adherence thresholds, proportion of participants that were drug users and study design. Nevertheless, even in the presence of high heterogeneity, meta-analysis has been suggested as a preferred option for data synthesis compared to qualitative or narrative interpretation; narrative synthesis can lead to misleading conclusions that should not be generalized beyond the scope of the analysis (Ioannidis, Patsopoulos, & Rothstein, 2008) . It is worth noting that the heterogeneity observed in the current study appears to be the norm rather than the exception in published ART adherence meta-analyses (Falagas, Zarkadoulia, Pliatsika, & Panos, 2008; Peltzer & Pengpid, 2013) . Another limitation is bias that can be introduced by the methods used for measuring adherence. Most of the studies included in this meta-analysis used selfreported adherence. Furthermore, this is a conservative bias given that self-report may overestimate adherence, the actual levels of ART adherence may be even lower than what we are reporting. Finally, the meta-regression analysis has several limitations. Meta-regression represents an observational association and suffers from ecological fallacy . In addition, meta-regression has low statistical power to detect an association and is easily influenced by an outlier (Lambert, Sutton, Abrams, & Jones, 2002) .
Despite these limitations, the study strengths are important. We conducted comprehensive searches of databases to ensure that all relevant, published studies were identified. We also conducted meta-regression analyses to investigate whether any particular study-level factor explained the results and could account for the observed variations between studies. In doing so, we have comprehensively and robustly reviewed existing literature in this area, which points to key gaps in the current literature on determinants of ART adherence.
Conclusion
Our meta-analysis showed ART adherence among prison inmates is significantly below that recommended for adequate virologic suppression. Only about half of the prisoners achieved optimal adherence (54.6%). Optimal adherence remains a challenge in prisoners and it is crucial to monitor ART adherence, investigate specific risk factors for non-adherence among prisoners and develop appropriate interventions. 
